Operating Lease, Right-of-Use Asset in USD of RECURSION PHARMACEUTICALS, INC. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Recursion Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Recursion Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $47.8M, a 0.15% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $47.8M -$70K -0.15% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $50.3M +$6.24M +14.1% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $53.2M +$17.7M +49.8% Mar 31, 2025 10-Q 2025-05-05
Q4 2024 $65.9M +$32.2M +95.7% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $47.9M +$13.8M +40.6% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $44.1M +$9.19M +26.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $35.5M +$385K +1.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $33.7M +$408K +1.23% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $34.1M +$336K +1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $34.9M +$256K +0.74% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $35.1M +$1.82M +5.45% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $33.3M +$33.3M Dec 31, 2022 10-K 2024-02-29
Q3 2022 $33.7M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $34.6M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $33.3M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $0 Dec 31, 2021 10-K 2023-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.